Pancreatic Cancer Research

ResearcherNorthern Jiangsu People's HospitalActive in the last 2 years

Yanbing Ding

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0689-2199; OpenAlex author ID A5049051407. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. MAFF drives pancreatic cancer progression through AKR1C1-mediated inhibition of ferroptosis. Co-author DOI 10.1093/qjmed/hcaf272↗
  2. Is Helicobacter pylori infection associated with pancreatic cancer? A systematic review and meta-analysis of observational studies. Last author DOI 10.1177/20406223231155119↗
  3. Significant increased CA199 levels in acute pancreatitis patients predicts the presence of pancreatic cancer. Co-author DOI 10.18632/oncotarget.23993↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ben‐Gang Zhou · 2 shared papers, 2023–2026 · strength 0.49
  2. Min Zhang · 1 shared paper, 2026 · strength 0.29
  3. Xin Jiang · 1 shared paper, 2026 · strength 0.29
  4. Dongling Teng · 1 shared paper, 2018 · strength 0.07
  5. Weiqin Li · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.